French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  The Lancet

• Publication date

  1994-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(94)91462-1PMID 7906761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

  1992cited by this paper
• The Impact of Diabetes on the CNS

  1992cited by this paper
• Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes

  1992cited by this paper
• Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies

  1991cited by this paper
• Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.

  1991cited by this paper
• Determination of Portal Insulin Absorption From Peritoneum via Novel Nonisotopic Method

  1990cited by this paper
• A preliminary trial of the programmable implantable medication system for insulin delivery.

  1989cited by this paper
• Incidence and Management of Severe Hypoglycemia in 434 Adults with Insulin-dependent Diabetes Mellitus

  1985cited by this paper

• Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems

  2025cites this paper
• Implantable drug delivery devices

  2021cites this paper
• L'insulinothérapie au xxie siècle : une symphonie de plus en plus harmonieuse

  2021cites this paper
• Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis

  2021cites this paper
• Implantable Drug Delivery Systems and Foreign Body Reaction: Traversing the Current Clinical Landscape

  2021cites this paper
• The Implantable Insulin Pump

  2019cites this paper
• Use of intraperitoneal insulin delivery for artificial pancreas

  2019cites this paper
• Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus

  2019cites this paper
• Exploration Study on Configurable Instruction Set for Bioinformatics' Applications

  2019cites this paper
• Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?

  2018cites this paper
• PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months

  2018cites this paper
• Diabète de type1: pompeàinsuline

  2017cites this paper
• A New Optimized Percutaneous Access System for CIPII

  2017cites this paper
• Continuous Intraperitoneal Insulin Infusion from Implantable Pumps

  2015cites this paper
• Clinical Results of an Automated Artificial Pancreas Using Technosphere Inhaled Insulin to Mimic First-Phase Insulin Secretion

  2015cites this paper
• Continuous intraperitoneal insulin infusion in the treatment of type 1 diabetes mellitus

  2015cites this paper
• Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation

  2015cites this paper
• Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus

  2014cites this paper
• Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia

  2014cites this paper
• Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up

  2014cites this paper
• Assessment of a New Insulin Preparation for Implanted Pumps Used in the Treatment of Type 1 Diabetes

  2014cites this paper
• Glycemic management of diabetes by insulin therapy.

  2013cites this paper
• Wearable and implantable pancreas substitutes

  2013cites this paper
• Materials for Diabetes Therapeutics

  2012cites this paper
• L’insuline par voie orale : promesses et réalités

  2012cites this paper
• Pompes à insuline externes et implantables dans le diabète de type 1 : bénéfices et perspectives

  2012cites this paper
• In search of improved glucose control: helping the patient decide between insulin injections and infusion pump therapy

  2012cites this paper
• Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes

  2012cites this paper
• Complications of continuous intraperitoneal insulin infusion with an implantable pump.

  2012cites this paper
• Can technological solutions for diabetes replace islet cell function?

  2011cites this paper
• A Recent Survey Confirms the Efficacy and the Safety of Implanted Insulin Pumps During Long-Term Use in Poorly Controlled Type 1 Diabetes Patients

  2011cites this paper
• Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.

  2011cites this paper
• Artificial Pancreas: Past, Present, Future

  2011cites this paper
• How technology has changed diabetes management and what it has failed to achieve.

  2011cites this paper
• Improvement of HbAi

  2010cites this paper
• Insulinothérapie : insuline ou analogues ? Injection ou perfusion ? Boucle ouverte ou boucle fermée ?

  2010cites this paper
• A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion

  2009cites this paper
• Intraperitoneal Insulin Infusion Versus Islet Transplantation: Comparative Study in Patients with Type 1 Diabetes

  2009influential citation
• Lösungsansätze bei frustraner Insulinpumpentherapie

  2009cites this paper
• Clinical experience with an implanted closed-loop insulin delivery system.

  2008cites this paper
• Insulin Delivery Route for the Artificial Pancreas: Subcutaneous, Intraperitoneal, or Intravenous? Pros and Cons

  2008cites this paper
• Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump

  2008cites this paper
• Implantable insulin pumps. A position statement about their clinical use.

  2007cites this paper
• The Artificial Pancreas: How Sweet Engineering Will Solve Bitter Problems

  2007cites this paper
• Diabetes Mellitus : Implications for Physical Therapy Pharmacologic Management of Hyperglycemia in

  2006cites this paper
• The EVADIAC experience

  2006cites this paper
• Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

  2006cites this paper
• Implantable Pump Therapy Restores Metabolic Control and Quality of Life in Type 1 Diabetic Patients With Buschke’s Nonsystemic Scleroderma

  2006cites this paper
• Closing the loop: combining insulin pumps and glucose sensors in children with type 1 diabetes mellitus

  2006cites this paper
• Management strategies for brittle diabetes.

  2006cites this paper
• Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

  2006cites this paper
• Subcutaneous insulin: pharmacokinetic variability and glycemic variability.

  2005cites this paper
• What could be the reasons for giving up the implanted pump treatment?

  2005cites this paper
• Aseptic peritonitis revealed through recurrent catheter obstructions in type 1 diabetic patients treated with continuous peritoneal insulin infusion.

  2004cites this paper
• Trasplante pancreático y tolerancia inmunológica

  2004cites this paper
• Implantable insulin delivery pumps

  2004cites this paper
• Glucose sensors: toward closed loop insulin delivery.

  2004cites this paper
• The Physiological Rationale for Oral Insulin Administration

  2004cites this paper
• Current status and future of implantable insulin pumps for the treatment of diabetes

  2004cites this paper
• Artificial and Bio‐artificial Pancreas Systems

  2003cites this paper
• [Treatment of insulin-dependent diabetes: new therapy by electromagnetic replacement: towards an artificial pancreas].

  2003cites this paper
• Reproducibility of plasma insulin kinetics during intraperitoneal insulin treatment by programmable pumps.

  2003cites this paper
• Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

  2003cites this paper
• Subcutaneous insulin infusion in type 1 diabetes mellitus

  2003cites this paper
• Open- and Closed-Loop Insulin Delivery Systems and Glucose Sensors

  2003cites this paper
• Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.

  2002cites this paper
• Continuous intraperitoneal insulin infusion in patients with ‘brittle’ diabetes: favourable effects on glycaemic control and hospital stay

  2002cites this paper
• Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.

  2002cites this paper
• Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients.

  2002cites this paper
• Artificial endocrine pancreas1

  2001cites this paper
• Insulin Pumps and Glucose Regulation

  2001cites this paper
• External and implantable insulin pumps: current place in the treatment of diabetes.

  2001cites this paper
• High antigenicity of intraperitoneal insulin infusion via implantable devices: preliminary rat studies.

  2001cites this paper
• HMR359 34__38

  2001cites this paper
• Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump.

  2001cites this paper
• Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.

  2000cites this paper
• Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.

  2000cites this paper
• Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.

  2000cites this paper
• Programmable Implantable Insulin Infusion Devices and Diabetes Care

  1999cites this paper
• Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment.

  1999cites this paper
• Implantable insulin pumps.

  1999cites this paper
• Local Adverse Events Associated With Long-Term Treatment by Implantable Insulin Pumps: The French EVADIAC Study Group experience

  1998cites this paper
• Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps

  1998cites this paper
• Long Term Safety and Efficacy of Intraperitoneal Insulin Infusion by Means of Implantable Pumps

  1998cites this paper
• Novel methods of insulin delivery: an update.

  1998cites this paper
• Advances Toward the Implantable Artificial Pancreas for Treatment of Diabetes

  1998influential citation
• Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.

  1998cites this paper
• Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.

  1998cites this paper
• Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs.

  1997cites this paper
• Catheter Survival During Long-Term Insulin Therapy With an Implanted Programmable Pump

  1997cites this paper
• Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

  1997cites this paper
• A study of the factors which may influence the isolation of porcine islets of Langerhans

  1997cites this paper
• Management of diabetes with glucose sensors and implantable insulin pumps. From the dream of the 60s to the realities of the 90s.

  1997cites this paper
• International Study Group for Implantable Infusion Devices 1996. The world's only implantable infusion pump society.

  1997cites this paper
• Frequent outpatient follow-up improves severe hypoglycaemia and moderate hyperglycaemia in insulin-dependent diabetic patients.

  1997cites this paper
• Use of an integrated sideport for diagnosis and management of decreased flow rates in a programmable implanted insulin delivery system. Implantable Insulin Pump Trial Study Group.

  1996cites this paper
• Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Evadiac Study Group.

  1996cites this paper
• Insulin Underdelivery From Implanted Pumps Using Peritoneal Route: Determinant role of insulin pump compatibility

  1996cites this paper
• [The implantable insulin pump in the treatment of diabetes. Hopes and reality?].

  1996cites this paper
• Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM

  1996cites this paper